Top Abstract Purchase Related
Home
>
Node
>
Subnode

Lung cancer

Furuse, K.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(13): 1917-1924

1997

ISSN/ISBN: 0385-0684
PMID: 9350236
Document Number: 475937
Recently, a number of novel chemotherapeutic agents under development show consider able promise in the treatment of lung cancer. Optimally, these new agents should exhibit a unique mechanism of action, a favorable toxicity profile in comparison to standard cisplatin-based chemotherapy, significant single agent activity (> 20% response rate, or > 40% 1-year survival rate) and synergistic antitumor effects with cisplatin and/or radiation. This review will describe the current development status of these new agents, including paclitaxel, docetaxel, vinorelbine, CPT-11, topotecan and gemcitabine.

Document emailed within 1 workday
Secure & encrypted payments

Hillerdal, G. 1999: Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer Lakartidningen 96(43): 4691
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
McCormack, V.A.; Hung, R.J.; Brenner, D.R.; Bickeböller, H.; Rosenberger, A.; Muscat, J.E.; Lazarus, P.; Tjønneland, A.; Friis, Søren.; Christiani, D.C.; Chun, E-Mi.; Le Marchand, L.; Rennert, G.; Rennert, H.S.; Andrew, A.S.; Orlow, I.; Park, B.; Boffetta, P.; Duell, E.J. 2011: Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO) Cancer Causes and Control: Ccc 22(12): 1709-1720
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
El-Akawi, Z.J.; Nusier, M.K.; Zoughool, F.E. 2006: Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients Saudi Medical Journal 27(2): 181-184
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
O'Rourke, M.A.; Feussner, J.R.; Feigl, P.; Laszlo, J. 1987: Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly JAMA 258(7): 921-926
Schreiber, G.; Pitterle, D.; Kim, Y.C.; Bepler, G. 1999: Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung Anticancer Research 19(2a): 1109-1115
Hijmering-Kappelle, L.B.M.; van der Wekken, A.J.; Hiltermann, T.J.N.; Groen, H.J.M. 2017: New biopsy at lung cancer progression: rational treatment of resistant lung cancer Nederlands Tijdschrift Voor Geneeskunde 161: D1229
Dhabhar, B.N.; Malhotra, H.; Advani, S.H. 1992: Incidence of lung cancer and advances in non-small cell lung cancer Journal of the Association of Physicians of India 40(7): 493
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Kuwahara, T. 1986: Cytodiagnosis of lung cancer. Immunohistochemical findings in lung cancer Rinsho Byori. Japanese Journal of Clinical Pathology 34 Spec no 66: 163-174
Kimura, I.; Ohnoshi, T.; Nakata, Y.; Nakata, Y.; Hiraki, S.; Miyake, K. 1980: Lung cancer: problems in the treatment of advanced lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 18(9): 572-577
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Asamura, H. 1997: State of the art treatment of lung cancer: non-small cell lung cancer--surgical treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 3): 366-372
Aoki, K.; Ogawa, H. 1980: Modern theories of the etiology of lung cancer: the theory of smoking as the etiology of lung cancer Nursing Technique 26(1): 27-33
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Jiang, F.; Xu, L.; Yuan, F.-l.; Huang, J.-f.; Lu, X.-x.; Zhang, X.-y. 2010: Lung auto-transplantation technique in the treatment for stage IIi central lung cancer Zhonghua Yi Xue Za Zhi 90(19): 1329-1332
Tsuchida, T. 2012: Introduction of "Approach to a solitary peripheral lung lesion suspected lung cancer" Nihon Geka Gakkai zasshi 113(5): 456-457